Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy...

8

©2017 Health Delegates. All Rights Reserved. November 2017 Top 20 Specialty Pipeline Report

Upload
others
Category

Documents
view
0
download
0

Embed Size (px):

Transcript of Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy...

$Page 1: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

November 2017Top 20 Specialty Pipeline Report

$Page 2: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

$Page 3: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

$Page 4: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

$Page 5: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

December 2017Top 20 Specialty Pipeline Report

$Page 6: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

$Page 7: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

$Page 8: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive$

©2017 Health Delegates. All Rights Reserved.

8.01.66 Chimeric Antigen Receptor Therapy for Multiple Myeloma

8.01.66 Chimeric Antigen Receptor Therapy for Multiple Myeloma

Relapsed Myeloma

Relapsed Myeloma

Chimeric antigen receptors (CAR). Chimeric antigen receptors (CAR) Chimeric antigen receptors (CAR) are recombinant receptors that provide both antigen-binding.

Chimeric antigen receptors (CAR). Chimeric antigen receptors (CAR) Chimeric antigen receptors (CAR) are recombinant receptors that provide both antigen-binding.

Released, Relapsed, Rehospitalized

Released, Relapsed, Rehospitalized

P1-27 T CELL GENE THERAPY TO ERADICATE DISSEMINATED … · Background: We created “designer T cells” (dTc) by retroviral gene therapy to express chimeric immunoglobulin-T cell

P1-27 T CELL GENE THERAPY TO ERADICATE DISSEMINATED … · Background: We created “designer T cells” (dTc) by retroviral gene therapy to express chimeric immunoglobulin-T cell

Chimeric Antigen Receptors

Chimeric Antigen Receptors

$Selection and Sequencing Therapy for Relapsed/Refractory CLL$

Selection and Sequencing Therapy for Relapsed/Refractory CLL

IMMUNOTHERAPY Reengineering chimeric antigen receptor T ... · IMMUNOTHERAPY Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease Christoph T.

IMMUNOTHERAPY Reengineering chimeric antigen receptor T ... · IMMUNOTHERAPY Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease Christoph T.

$Clinical Updates & Issues: Relapsed/Refractory Multiple ... NCCN Beth Faiman.pdf · Relapsed/Refractory Myeloma • Disease‐related factors – Duration of response to initial therapy$

Clinical Updates & Issues: Relapsed/Refractory Multiple ... NCCN Beth Faiman.pdf · Relapsed/Refractory Myeloma • Disease‐related factors – Duration of response to initial therapy

CAR T Cell Therapy - Amazon Web Services · CAR T Cell Therapy Chimeric Antigen Receptor T cell therapy, or CAR T cell therapy, is an immunotherapy approach to treat cancer. Approaches

CAR T Cell Therapy - Amazon Web Services · CAR T Cell Therapy Chimeric Antigen Receptor T cell therapy, or CAR T cell therapy, is an immunotherapy approach to treat cancer. Approaches

Chimeric Antigen Receptor T - Cell Therapy for B-Cell ...

Chimeric Antigen Receptor T - Cell Therapy for B-Cell ...

Hemophilia B Gene Therapy in Mice using a Novel Chimeric ...€¦ · + Proof of concept for CB 2679d-GT . vs . Padua: Collaboration with Vrije University, Brussels + A novel chimeric

Hemophilia B Gene Therapy in Mice using a Novel Chimeric ...€¦ · + Proof of concept for CB 2679d-GT . vs . Padua: Collaboration with Vrije University, Brussels + A novel chimeric

CAR T Cell Therapy - pfe-pfizercom-d8-prod.s3.amazonaws.com › ... · Patient CAR T cells CAR T Cell Therapy Chimeric Antigen Receptor T cell therapy, or CAR T cell therapy, is an

CAR T Cell Therapy - pfe-pfizercom-d8-prod.s3.amazonaws.com › ... · Patient CAR T cells CAR T Cell Therapy Chimeric Antigen Receptor T cell therapy, or CAR T cell therapy, is an

Relapsed Chronic Myeloid Leukemia: new players in targeted therapy

Relapsed Chronic Myeloid Leukemia: new players in targeted therapy

Exploiting the Immune System: Chimeric Antigen Receptor-T Cell …ncop.memberlodge.org/resources/Documents/CAR-T therapy slides.p… · Exploiting the Immune System: Chimeric Antigen

Exploiting the Immune System: Chimeric Antigen Receptor-T Cell …ncop.memberlodge.org/resources/Documents/CAR-T therapy slides.p… · Exploiting the Immune System: Chimeric Antigen

Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for ...

Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for ...

European recommendation for salvage therapy of relapsed acute ... · European recommendation for salvage therapy of relapsed acute promyelocytic leukemia (APL) including arsenic trioxide

European recommendation for salvage therapy of relapsed acute ... · European recommendation for salvage therapy of relapsed acute promyelocytic leukemia (APL) including arsenic trioxide

Languages

Pages

Legal

Copyright © 2022 FDOCUMENTS